1. Field of the Invention
The invention relates to use of electromagnetic energy to enhance wound healing and to minimize or prevent scar formation.
2. Description of the Related Art
Fractional electromagnetic energy is used to treat a variety of skin and tissue conditions and pathologies. Such treatments typically employ light-based devices such as lasers and RF devices to deliver energy to the epidermis and/or the dermis of a subject's skin. Controlled applications of light energy penetrate to various depths of the skin. Energy penetration results in localized heat deposition through the subsurface of the skin as well as localized thermal damage within the epidermis and/or dermis, depending upon the depth of penetration. Thermal damage within the skin at treatment sites and, in some cases throughout the surrounding adjacent tissue, causes immediate and long-term, natural healing effects within the affected tissue. Such natural healing effects include collagen contraction and stimulation of collagen formation, which result in a macro effect of collagen regeneration throughout the underlying skin layers.
A number of skin treatments are possible with lasers and RF devices. For example, such device may be used for relatively superficial treatments of the epidermal layers for treatment of fine lines, skin texture, pigmentation (dyschromia) and sun damage, as well as deeper treatments of the epidermal and dermal layers for treatment of deep wrinkles and scars. Non-limiting examples of such devices are described in U.S. Pat. Nos., 6,328,733; 6,451,010; 6,758,845; and 7,438,712, which are all expressly incorporated by reference herein in their entireties.
However, a need remains for a safe, effective electromagnetic energy-emitting devices and methods to enhance wound healing and reduce scar formation.
In one embodiment, a method of reducing scar formation associated with a skin wound, includes: providing an electromagnetic energy source; delivering energy from the electromagnetic energy source to opposing edges of a skin wound; and sealing the wound after delivering the energy. The electromagnetic energy source can include a laser, a fractional laser, or a CO2 laser.
The method can include scanning a pattern of treatment spots over a treatment area around the skin wound. In one embodiment, the treatment area is circular with a diameter in a range of from about 1.3 mm to about 20 mm, or about 10 mm. The delivering energy can include delivering laser light having a wavelength in a range of from about 9400 nm to about 11100 nm, delivering laser light in a range of from about 5.2 J/cm2 to about 445 J/cm2, delivering laser light having a pulse width in a range of from about 20 microseconds to about 1000 microseconds, delivering laser light having a spot density in a range of from about 5% to about 100%, and/or creating a plurality of channels in the skin around the wound, each channel having a depth of about 40 microns to about 1500 microns.
The sealing can include suturing the wound closed, delivering a surgical staple to skin near the skin wound to close the wound, delivering a tissue glue to the skin wound to close the wound, and/or tissue welding.
The method can also include everting the wound prior to delivering energy from the electromagnetic energy source. The method can also include delivering additional energy from the electromagnetic energy source to opposing edges of the skin wound after sealing.
In another embodiment, a method of reducing scar formation associated with a skin wound includes: providing a laser system comprising a laser and a scanning handpiece optically coupled to the laser, the scanning handpiece configured to direct laser energy from the laser to a treatment area on a patient's skin to form a plurality of spots on the patient's skin within the treatment area; aligning an aiming beam emitted from said handpiece with respect a wound on the patient's skin; activating the laser and handpiece to direct the laser energy from the laser to the treatment area on the patient's skin to form the plurality of spots on the patient's skin, wherein said treatment area comprises at least first and second portions spaced apart from each other and located on opposite sides of said aiming beam such that at least some of said laser energy is delivered to skin near the wound's edges; and sealing the wound after scanning said laser beam within the treatment area. The first and second portions can be spaced apart from each other by about a width of the wound or by at least the width of the wound. In some embodiments, the spacing between the first and second portions is changed based upon the width of the wound. For example, in some embodiments, the spacing between the first and second portions is changed automatically based upon the width of the wound, for example, by a sensor located in the handpiece that optically or mechanically senses the wound's width.
In another embodiment, an electromagnetic energy system configured to reduce scar formation associated with a skin wound includes: an electromagnetic energy source configured to generate an electromagnetic energy beam having a plurality of beam parameters; an optical energy conduit having a proximal and a distal end, the optical energy conduit coupled to the electromagnetic energy source at the proximal end; a handpiece coupled to the distal end of the optical energy conduit; and a memory, comprising predetermined, stored values of the plurality of beam parameters, the predetermined values of the beam parameters configured to reduce scar formation associated with a skin wound.
The beam parameter can include a pulse width, a treatment area size, a treatment area shape, a spot size, a power level, a fluence, and/or a penetration depth. The electromagnetic energy source can include a laser, a CO2 laser, and/or a fractional laser. The electromagnetic energy system can also include an aiming beam configured to be aligned with a wound prior to delivering energy from the electromagnetic energy source to a treatment area near the wound. In one embodiment, the treatment area is spaced a predetermined distance from the aiming beam. The aiming beam can be formed as a line or a curve.
In yet another embodiment, a handpiece for delivering electromagnetic energy to a tissue treatment site to reduce scar formation associated with a wound at the treatment site includes: a housing; a connector attached to a proximal end of the housing; a scanning system located at least partially within the housing and configured to receive electromagnetic energy from an electromagnetic energy source and deliver the electromagnetic energy within a treatment area at a treatment site on a patient's skin as a user-controllable pattern of spots within the treatment area; and a tissue eversion system protruding at least partly beyond a distal end of the housing, the tissue eversion system configured to evert tissue around a wound at the treatment site prior to delivering the electromagnetic energy.
The tissue eversion system can include first and second legs, wherein a distance between the first and second legs is controllable by a user. The handpiece can also include a sensor configured to determine a spacing between the first and second legs. The handpiece can control a diameter of the treatment area in response to the distance between the first and second legs.
The legs can include a material that doesn't reflect a substantial portion of electromagnetic energy incident upon the leg. The material can include a non-reflective coating. The handpiece can also include a medication delivery system configured to deliver a medication to the treatment site during delivery of the electromagnetic energy. The handpiece can also include a wound sealing system configured to seal the wound after delivery of electromagnetic energy. The handpiece can also include a control located on housing configured to activate the tissue eversion system.
In another embodiment, a handpiece for delivering electromagnetic energy to a tissue treatment site to reduce scar formation associated with a wound at the treatment site, the handpiece includes: a housing; a connector attached to a proximal end of the housing; a scanning system located at least partially within the housing and configured to receive electromagnetic energy from an electromagnetic energy source and deliver the electromagnetic energy within a treatment area at a treatment site on a patient's skin as a user-controllable pattern of spots within the treatment area; and a medication delivery system located at least partially within the housing and configured to deliver a medication to tissue around a wound at the treatment site during delivery of the electromagnetic energy.
The medication delivery system can include a removable cartridge containing the medication. The medication can include one or more of a drug, a steroid, Cortisone, 5-fluorouracil, an anti-cancer drug, an antimycotic, an anti-fungal drug, and a liposome. The medication delivery system can include a nozzle configured to spray the medication towards the treatment site. The handpiece can also include a control located on the housing, the control configured to activate the medication delivery system.
In yet another embodiment, a handpiece for delivering electromagnetic energy to a tissue treatment site to reduce scar formation associated with a wound at the treatment site includes: a housing; a connector attached to a proximal end of the housing; a scanning system located at least partially within the housing and configured to receive electromagnetic energy from an electromagnetic energy source and deliver the electromagnetic energy within a treatment area at a treatment site on a patient's skin as a user-controllable pattern of spots within the treatment area; and a wound sealing system located at least partially within the housing and configured to hold closed a wound at the treatment site after delivery of the electromagnetic energy.
The wound sealing system can include a stapler, a tissue glue, and/or a tissue welding system. The handpiece can also include a control located on the housing, the control configured to activate the wound sealing system.
Fractional light treatments of skin and tissue include microablative techniques that employ, for instance, laser radiation to ablate microchannels within the skin layers at controlled depths and widths. Surrounding tissue adjacent and between microchannels does not experience thermal damage along the microchannels, although thermal effects are exhibited throughout the layers of surrounding tissue. This results in the noted macro effect, discussed above, throughout the skin layers and advantageous long-term effects on the structure of the skin layers.
Referring to
Referring to
As shown in
Microablative techniques for fractional light treatment often employ fractional CO2 lasers that may emit radiation at wavelengths of up to 10,600 nm. In particular, the patterned light radiation as described above may be delivered to treatment areas at high fluences (e.g., high energy density per laser pulse) for facial skin treatment applications and lower fluences (e.g., low energy density per laser pulse) for non-facial skin treatment applications. High energy density per pulse enables deep penetration, for instance, into the dermis of facial skin for immediate collagen contraction and stimulation of collagen formation.
In one embodiment, microablative techniques employing the patterned treatment spots described above apply radiation energy to only a small area or volume of subsurface tissue relative to the overall scanned area of skin. A relatively broad treatment area of the skin may be scanned with a radiation delivery device. Yet, the delivery device emits radiation energy in a given pattern of treatment spots that applies energy to only a fraction of the subsurface tissue underlying the scanned area of skin. Radiation energy is absorbed by the skin and creates microchannels without exposing the surrounding tissue. As mentioned, the ablative techniques of micro channel formation create healing effects throughout the surrounding adjacent tissue that results in an advantageous macro effect throughout the subsurface tissue.
In addition to CO2 lasers, fractional light treatment using microablation techniques may also employ iridium lasers and other lasers. Fractional light treatments also include procedures that may use non-ablative techniques that may employ general Nd:YAG and other lasers operative in non-ablative modes, as well as arrays of RF needle electrodes.
Referring to
In one configuration of the method, a fractional CO2 laser was employed to deliver pulsed light energy 24 to each of the edges 20 and 22 of a surgical incision site 26 in facial tissue at the time of excision and prior to suturing. The surgical sites 26 were a minimum of about 2 cm in length. The treatment spot was about 10 mm. The treatment spot included an overlap between adjacent treatment spots of about 5 mm.
Other parameters of the laser beam produced with the fractional CO2 laser employed in the surgical wound pretreatment include light radiation having wavelengths in a range of from about 9,400 nm to about 11,100 nm, and energy density or fluence in a range of from about 5.2 Joules/cm2 to about 445 Joules/cm2 that was delivered with a pulse width in a range of from about 20 μs to about 1000 μs.
The treatment area can include about 1.3 mm to 20 mm of scan area and further included a spot density of between 5% and 100%. A penetration depth is estimated to be in the range of from about 40 μm per pulse to about 1500 μm per pulse.
One study performed according to one embodiment of the invention included ten Mohs micrographic surgery patients. Surgical incision sites were treated intraoperatively with a fractional CO2 laser in a randomized split fashion whereby half of a given incision site was treated with microablative light treatment and the remaining half of the incision site was left untreated before the incision site was sutured. The patients were seen and the incisions were photographed within one week of surgery and thereafter within two to three months of surgery. Scar questionnaires were completed at that time. Three physicians served as blinds to evaluate and rate the incision photographs.
The results indicate that eight of the ten patients had a significant improvement in the half of the incision sites that were treated with the fractional CO2 laser energy. Excellent agreement between patient observations and the blind physician ratings occurred.
The results indicate that the fractional CO2 treatment of the incision edges 20 and 22 at the time of excision, and prior to suturing of the incision, is significantly effective for minimizing the appearance of subsequent scar formation compared to the control surgical sites that did not receive such pretreatment.
The results further suggest that applications of high fluences of CO2 light energy to facial wounds enhance wound healing and help to reduce scar formation subsequent to surgical procedures.
The results also suggest broader applications of fractional CO2 light treatment to reduce scar formation after surgical intervention of non-facial tissue. In these cases, the fractional CO2 light treatment may be delivered at lower fluences. In addition, the results suggest that applications of fractional CO2 light treatment for non-surgical wound healing of both facial and non-facial tissue may be effective.
The therapeutic methods described herein may be performed with a variety of electromagnetic energy-emitting devices, including lasers, intense pulsed light, radiofrequency (RF) energy sources, as well as others. Indeed, iridium, erbium (e.g., Er:YAG and/or Er, Cr:YSGG), neodymium (e.g., Nd:YAG), and a variety of solid-state or diode laser devices may be employed to delivery light energy to surgical and non-surgical wounds to enhance healing and to help to minimize or prevent consequent scar formation according to any one or more of the methods discussed herein.
The invention also anticipates that other non-ablative light energy based treatments may be employed and may be effective fractional light treatments for enhancing surgical and non-surgical wound healing and for minimizing scar formation. For example, any laser configured for operating in a non-ablative fractional mode may be effective. Other electromagnetic-energy-based devices, such as RF electrode needles, may provide effective results, as well.
Another embodiment of a method of enhancing healing and minimizing or preventing scar formation is illustrated in
The electromagnetic energy can be delivered with a scanning handpiece that scans a treatment beam over a treatment area and delivers a sequence of overlapping, abutting, and/or spaced-apart energy spots to the treatment area. In one embodiment, the electromagnetic energy source includes a fractional energy source, which spaces treatment spots apart from one another, for example, in the manner illustrated above with respect to
The method 40 proceeds to block 46, during which the clinician closes the surgical wound. For example, at block 46 the clinician may suture, staple, glue, or weld the treated tissue to close the surgical wound. Optionally, the method can further include an additional block (not shown), during which the clinician delivers a subsequent electromagnetic energy treatment to the closed surgical wound.
Another embodiment of a method of enhancing healing and minimizing or preventing scar formation is illustrated in
The electromagnetic energy can be delivered according to any of the methods described herein with a scanning or a non-scanning handpiece. A scanning handpiece typically includes one or more movable optics, such as a spinning mirror, that scans a treatment beam over a treatment area while the handpiece is held stationary at a treatment location on the patient's skin. The scanning treatment beam results in a sequence of overlapping, abutting, and/or spaced-apart spots within the treatment area. The treatment spots are generally circular in shape, and can be delivered within a variety of treatment area shapes and sizes, including square, triangular, rectangular, circular, hexagonal, trapezoidal, parallelogram, rhombus, linear, or annular shapes.
In one embodiment, the electromagnetic energy source includes a fractional energy source, which spaces treatment spots apart from one another, for example, in the manner illustrated above with respect to
One embodiment of a system 60 configured to perform methods of using electromagnetic energy to enhance wound healing and to minimize or prevent scar formation is illustrated in
In one embodiment, the laser 70 includes a CO2 laser that emits a beam of light having a wavelength of 10,600 nm. The laser 70 can operate in a pulsed or continuous mode, and deliver up to 240 W of power to a treatment site. The control system 71 includes a microprocessor and/or other electronic hardware and software to control system operation according to input received from the user interface 72. In one embodiment, the control system 71 includes a memory configured to store data or presets relating to one or more beam parameter settings. For example, the memory can store predetermined beam parameter setting values and it can store user-configurable beam parameter setting values. The beam parameter settings correspond to any of a variety of electromagnetic energy, light, and/or laser parameters, including but not limited to: pulse width, average power, peak power, duty cycle, energy, fluence, treatment area shape, spot density, spot size, depth of penetration, etc. The energy conduit 64 includes a waveguide, articulated arm, and/or fiberoptic delivery system to conduct electromagnetic energy from the energy source 62 to the handpiece 66.
The laser beam spot sizes can be controlled to have a variety of diameters by adjusting corresponding setting on the user interface 72. For example, the laser beam's spot sizes can be controlled to have a diameter of 120, 200, 1000, 1300, or 2000 μm. The handpiece 66 includes scanning optics to provide fractional lasing of the target tissue surface.
In one embodiment illustrated in
The alignment beam 76 provides a reference point (or line) with respect to the treatment areas 77 of the therapeutic energy from the laser 70. For example, as illustrated in
One embodiment of a user interface 80 is illustrated in
In one embodiment, the beam parameter controls 84 also allow the user to control the shape, size, color and/or brightness of the alignment beam 78 (as discussed above with respect to
The presets 86 are user-selectable configurations that correspond to a group of beam parameter controls relevant to a particular clinical therapy. For example, the user interface 80 can include a preset 86 corresponding to “Surgical Scar Reduction,” which when selected would set one or more beam parameter controls to predetermined levels, such as the levels or settings discussed above. The preset 86 adjusts a combination of beam parameters to result in an overall system 60 setting that provides electromagnetic energy to enhance wound healing and to minimize or prevent scar formation.
One embodiment of a scanning laser handpiece 66 adapted to enhance wound healing and minimize or prevent scar formation is illustrated in
For example, the medication delivery system 92 can include a tubing, pump, spray or other device adapted to eject a liquid or cream from a handpiece output 94 to a treatment site on the patient's skin. The medication delivery system 92 can include a user-changeable cartridge, such as a single-use cartridge, that includes the medication.
The medication can include one or more of a drug, steroid, Cortisone, 5-fluorouracil, an anti-cancer drug, an antimycotic (e.g., anti-fungal) drug, or a liposome. Such substances can help with wound healing and scar reduction and prevention. In some embodiments, the flow rate of the medication is controlled in response to beam parameter controls 84 or presets 86 selected by the user. For example, in one embodiment, when the beam penetration depth, diameter, power, or fluence is increased, the medication delivery rate is increased, as well. Similarly, as these parameters are decreased, the medication delivery rate is decreased, as well.
The medication is delivered from the medication output 94 to the tissue treatment site before, during, and/or after deliver of electromagnetic energy. In some embodiments, the handpiece 66 includes a roller ball or cylinder, or a spatula arm that spreads the medication over the treatment area during and after treatment.
In another embodiment, as illustrated in
In one embodiment, the tissue eversion system 100 includes two tissue-contacting arms 102 that rotate with respect to each other about a pivot 104. Each arm 102 includes a first portion that extends in substantially the same direction as the handpiece's longitudinal axis, and second, leg portion 106, that extends at an angle of about 90 degrees with respect to the first portion. The legs 106 of tissue eversion system 100 are elongated and space apart sufficiently to be placed on opposite sides of a wound 112, as shown in
Activating the tissue eversion system's control 101 causes one or both arms 102 to rotate with respect to each other, which causes the legs 106 to move towards each other, as well. When the legs 106 are contacting tissue 110 on opposite sides of a wound 112, activating the control 101 therefore causes the opposing edges 114 of the wound to press against each other, and lift or evert a predetermined distance 116, as shown in
Electromagnetic energy is then delivered from the handpiece 66 while the tissue eversion system 100 stabilizes the wound 112 in an everted configuration. After treatment is completed and while the tissue is everted, the clinician can stitch, suture, or otherwise secure the wound in its closed configuration. Everting the tissue can eliminate the formation of dimples or other noticeable skin changes once the surgical wound 112 has healed.
In one embodiment, a method of treating tissue with an everting, electromagnetic-energy-emitting handpiece includes: aligning a tissue eversion system with a wound, everting the tissue (e.g., pinching opposing sides of the wound together to lift the edges), applying fractional laser energy to the everted wound, and suturing the wound while everted.
In another embodiment, the tissue eversion system 100 includes a sensor (not shown) that detects the spacing between the system's legs 106. For example, the sensor can include an optical sensor that responds to a material or a coating on each leg 106. In another embodiment, the sensor merely keeps track of the distance (or angle) that each arm 102 has been moved (e.g., rotated), and then calculates the spacing between the system's legs 106.
To avoid directing electromagnetic energy to the legs 106, the tissue eversion system 100 can provide an alarm to the user if it determines that the selected treatment area's size is too large, such that therapeutic energy (e.g., fractional laser light) will be directed to the tissue eversion system's legs 106. In another embodiment, the tissue eversion system 100 automatically changes the therapeutic treatment area's size automatically, for example, as the spacing between legs 106 changes.
In yet another embodiment, as illustrated in
In addition, the handpiece 66 may include more than one of the features described herein. For example, the handpiece 66 may include two or more of a medication delivery system, a tissue eversion system, and a wound sealing system. In some embodiments the handpiece 66 includes all three systems. In others, the handpiece 66 includes a tissue everting system and a wound sealing system. In such embodiments, the wound sealant may be delivered prior to eversion (e.g., apply a tissue glue prior to eversion) and/or after eversion (e.g., deliver a surgical staple or provide heat, such as laser energy, to cause tissue welding).
Although certain embodiments and examples have been described herein, it will be understood by those skilled in the art that the present inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the present inventive subject matter herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
This application is a continuation of U.S. application Ser. No. 13/049,748, filed Mar. 16, 2011, now U.S. Pat. No. 8,778,002, which claims priority from U.S. Provisional No. 61/314,560, filed Mar. 16, 2010, both of which are expressly incorporated by reference in their entireties. This application also incorporates by reference in its entirety U.S. application Ser. No. 13,049,747, filed Mar. 16, 2011, published as U.S. Publication No. 2011/0230817, now abandoned.
Number | Date | Country | |
---|---|---|---|
61314560 | Mar 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13049748 | Mar 2011 | US |
Child | 14331223 | US |